Am J Obstet Gynecol. 2008 Jan;198(1):30.e1-7.



Do short-term markers of treatment efficacy predict long-term se quelae of pelvic inflammatory disease?
Trautmann GM, Kip KE, Richter HE, Soper DE, Peipert JF, Nelson DB, Trout W, Schubeck D, Bass DC, Ness RB.



University of Pittsburgh School of Public Health, Pittsburgh, PA 15261, USA.


Objectives:

This study was undertaken to assess whether short-term markers, often used to measure clinical cure after treatment for pelvic inflammatory disease, predict se quelae of lack of pregnancy, recurrent pelvic inflammatory disease, and chronic pelvic pain.

Study Design:

Women with mild-to-moderate pelvic inflammatory disease were assessed after treatment initiation at 5 days for tenderness (n = 713) and at 30 days for tenderness, cervical infections and endometritis (n = 298). Pregnancy, recurrent pelvic inflammatory disease, and chronic pelvic pain were evaluated after 84 months, on average.

Results:

Pelvic tenderness at 5 and at 30 days significantly elevated the risk for developing chronic pelvic pain; tenderness at 30 days was also significantly associated with recurrent pelvic inflammatory disease. However, pelvic tenderness at 5 and at 30 days was only modestly clinically predictive of chronic pelvic pain or recurrent pelvic inflammatory disease (positive predictive values 22.1-66.9%). No short-term marker significantly influenced the likelihood of achieving a pregnancy.

Conclusion:

Tenderness at 5 or 30 days did not accurately predict the occurrence of pelvic inflammatory disease-related reproductive morbidities.


Women's Health



women's health


Please click on the required question.





Your Own Web Presence

 

For £35

 

 

FirstWebSiteDesign.com

 

Have your own web ad on the internet and optimized for good positioning.

 

Your Own Dedicated Web Page Designed Specifically For You

 

More Effective

Than Your Own

Single Page Website

 

For £35

 

 

FirstWebSiteDesign.com